Jian Ding

10PUBLICATIONS
42CO-AUTHORS
Haematological tumoursMolecular targetsAllergyEvolution of developmental systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 29, 2026
Low-dose antiangiogenic multikinase inhibitor AL3810 synergizes with PD-1 blockade by reducing CSF1-driven MHC-IIint tumour-associated macrophages to optimize TIM-3+ CD8+ T-cell effector function.

|Jun 18, 2025
PI3K-dependent GAB1/Erk phosphorylation renders head and neck squamous cell carcinoma sensitive to PI3Kα inhibitors.

Xu Zhang, Jiao Xu, Xuan Wang

|Mar 15, 2025
USP7 V517F mutation as a mechanism of inhibitor resistance.

Yu-Ling Miao, Fengying Fan, Yong-Jun Cheng

|Aug 14, 2024
Branched-chain amino acid transaminase 1 confers EGFR-TKI resistance through epigenetic glycolytic activation.

Tao Zhang, Zilu Pan, Jing Gao

|Mar 19, 2024
Oncogenic KRAS Induces Arginine Auxotrophy and Confers a Therapeutic Vulnerability to SLC7A1 Inhibition in Non-Small Cell Lung Cancer.

Xiameng Gai, Yingluo Liu, Xiaojing Lan

|May 14, 2023
SYK-mediated epithelial cell state is associated with response to c-Met inhibitors in c-Met-overexpressing lung cancer.

Ji Zhou, Xu-Chao Zhang, Shan Xue

Pageof 2

Frequent Collaborators

3 joint publications

Meiyu Geng

2 joint publications

Xuekui Yu

2 joint publications

Linghua Meng

1 joint publications

Li Sun